Endo Launches Fortesta, Raises 2011 Guidance
This article was originally published in The Pink Sheet Daily
Executive Summary
Three years after a new management team stepped in at Endo Pharmaceuticals, the specialtypharma appears to be using M&A to diversify successfully beyond its core pain franchise.